Avadel Pharmaceuticals Ownership | Who Owns Avadel Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Avadel Pharmaceuticals Ownership Summary


Avadel Pharmaceuticals is owned by 46.60% institutional investors, 1.13% insiders, and 52.27% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.25% of AVDL shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.81% of its assets in Avadel Pharmaceuticals shares.

AVDL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAvadel Pharmaceuticals46.60%1.13%52.27%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.82%11.62%67.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de7.04M7.25%$151.74M
Vanguard group5.86M6.04%$126.39M
Gendell jeffrey l4.77M4.91%$102.78M
Polar capital4.00M4.13%$61.07M
Vivo capital2.68M2.77%$40.99M
State street2.29M2.37%$35.01M
Geode capital management2.16M2.22%$46.48M
Tang capital management2.10M2.17%$32.03M
Highbridge capital management2.05M2.11%$44.15M
Wealth effects1.89M1.95%$40.77M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Wealth effects1.89M12.75%$40.77M
Krensavage asset management955.86K6.22%$14.60M
Knoll capital management600.00K5.68%$8.44M
Lion point capital, lp59.70K5.18%$911.62K
Vivo capital2.68M3.30%$40.99M
Tri locum partners lp724.86K2.54%$11.07M
Iridian asset management llc/ct247.09K1.96%$5.32M
Gendell jeffrey l4.77M1.79%$102.78M
Highbridge capital management2.05M1.41%$44.15M
Samsara biocapital675.50K1.35%$10.31M

Top Buyers

HolderShares% AssetsChange
Highbridge capital management2.05M1.41%2.05M
Kennedy capital management1.63M0.55%645.55K
Marshall wace, llp525.71K0.01%525.71K
Alpine associates management525.55K0.75%525.55K
Credit industriel et commercial522.03K0.86%522.03K

Top Sellers

HolderShares% AssetsChange
Janus henderson group---12.92M
Rtw investments, lp---8.80M
Two seas capital lp---5.37M
Brandes investment partners, lp218.43K0.04%-5.23M
Braidwell lp---4.11M

New Positions

HolderShares% AssetsChangeValue
Highbridge capital management2.05M1.41%2.05M$44.15M
Alpine associates management525.55K0.75%525.55K$11.33M
Credit industriel et commercial522.03K0.86%522.03K$11.25M
Groupe la francaise479.29K0.14%479.29K$10.33M
Gabelli & co investment advisers297.57K0.96%297.57K$6.41M

Sold Out

HolderChange
Principal securities-9.00
Clearstead advisors-15.00
Stephens consulting-45.00
Fortitude family office-55.00
Bell investment advisors-62.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025143-28.14%45,251,799-42.80%460.70%72-28.00%47-18.97%
Sep 30, 20251919.14%78,368,614-2.77%811.16%974.30%5510.00%
Jun 30, 2025173-6.99%80,562,7284.59%831.31%92-7.07%48-2.04%
Mar 31, 20251855.71%77,012,100-3.02%791.17%9911.24%486.67%
Dec 31, 20242-60.00%137,001-87.20%-11.52%----100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Polar Capital Healthcare Opports Inc3.69M3.81%-
Vanguard Total Stock Mkt Idx Inv3.08M3.13%-68.91K
Vanguard US Total Market Shares ETF2.99M3.09%-
iShares Russell 2000 ETF2.19M2.23%2.19M
Janus Global Life Science AUSD1.89M1.95%-131.51K
Janus Henderson Glb Life Scn I2 USD1.72M1.78%-159.56K
Polar Capital Biotech S Inc1.50M1.56%-
Janus Henderson Venture D1.48M1.53%-
Janus Henderson US Small Cap Growth1.48M1.53%-
Janus Henderson US Small Cap Growth MA1.44M1.47%1.44M

Recent Insider Transactions


DateNameRoleActivityValue
Feb 13, 2026Weiss Asset Management LP Former 10% OwnerSell$233.35M
Jan 21, 2025Palczuk Linda-Buy$39.64K
Jan 13, 2025Thornton Peter J.-Buy$80.45K
Jan 13, 2025Ende Eric J-Buy$235.22K
Dec 13, 2024MCHUGH THOMAS S Chief Financial OfficerBuy$24.02K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q3--
2025 Q2--
2025 Q13-
2024 Q47-

AVDL Ownership FAQ


Who Owns Avadel Pharmaceuticals?

Avadel Pharmaceuticals shareholders are primarily institutional investors at 46.60%, followed by 1.13% insiders and 52.27% retail investors. The average institutional ownership in Avadel Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Avadel Pharmaceuticals exceeds.

Who owns the most shares of Avadel Pharmaceuticals?

Avadel Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (7.04M shares, 7.25%), Vanguard group (5.86M shares, 6.04%), and Gendell jeffrey l (4.77M shares, 4.91%). Together, they hold 18.20% of Avadel Pharmaceuticals’s total shares outstanding.

Does Blackrock own Avadel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Avadel Pharmaceuticals.

Who is Avadel Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Wealth effects is Avadel Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.75% of its assets in 1.89M Avadel Pharmaceuticals shares, valued at 40.77M$.

Who is the top mutual fund holder of Avadel Pharmaceuticals shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Avadel Pharmaceuticals shares, with 3.81% of its total shares outstanding invested in 3.69M Avadel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools